Surveillance and medical therapy following endovascular treatment of chronic cerebrospinal venous insufficiency

Vascular. 2012 Jun;20(3):121-3. doi: 10.1258/vasc.2011.cm0009. Epub 2012 May 10.


The debate regarding the possible link between chronic cerebrospinal venous insufficiency and multiple sclerosis (MS) is continuously becoming more and more contentious due to the current lack of level 1 evidence from randomized trials. Regardless of this continued uncertainty surrounding the safety and efficacy of this therapy, MS patients from Canada, and other jurisdictions, are traveling abroad to receive central venous angioplasty and, unfortunately, some also receive venous stents. They often return home with few instructions regarding follow-up or medical therapy. In response we propose some interim, practical recommendations for post-procedural surveillance and medical therapy, until further information is available.

MeSH terms

  • Angioplasty
  • Azygos Vein
  • Cerebrovascular Disorders / complications
  • Cerebrovascular Disorders / surgery*
  • Chronic Disease
  • Continuity of Patient Care*
  • Endovascular Procedures* / adverse effects
  • Humans
  • Jugular Veins
  • Medical Tourism*
  • Multiple Sclerosis / etiology*
  • Stents / adverse effects
  • Venous Insufficiency